These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26157576)

  • 61. β-Catenin Directs Long-Chain Fatty Acid Catabolism in the Osteoblasts of Male Mice.
    Frey JL; Kim SP; Li Z; Wolfgang MJ; Riddle RC
    Endocrinology; 2018 Jan; 159(1):272-284. PubMed ID: 29077850
    [TBL] [Abstract][Full Text] [Related]  

  • 62. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Paracrine and endocrine functions of osteocytes.
    Michigami T
    Clin Pediatr Endocrinol; 2023; 32(1):1-10. PubMed ID: 36761497
    [TBL] [Abstract][Full Text] [Related]  

  • 64. THE CRUCIAL ROLE OF THE WNT SYSTEM IN BONE REMODELLING.
    Grigorie D; Lerner UH
    Acta Endocrinol (Buchar); 2018; 14(1):90-101. PubMed ID: 31149241
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.
    Maupin KA; Droscha CJ; Williams BO
    Bone Res; 2013 Mar; 1(1):27-71. PubMed ID: 26273492
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Overexpression of Lrp5 enhanced the anti-breast cancer effects of osteocytes in bone.
    Liu S; Wu D; Sun X; Fan Y; Zha R; Jalali A; Feng Y; Li K; Sano T; Vike N; Li F; Rispoli J; Sudo A; Liu J; Robling A; Nakshatri H; Li BY; Yokota H
    Bone Res; 2021 Jul; 9(1):32. PubMed ID: 34230453
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Endocrine Functions of Sclerostin.
    Riddle RC
    Curr Opin Endocr Metab Res; 2023 Feb; 28():. PubMed ID: 36713826
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mechanical Loading-Driven Tumor Suppression Is Mediated by Lrp5-Dependent and Independent Mechanisms.
    Feng Y; Liu S; Zha R; Sun X; Li K; Robling A; Li B; Yokota H
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33450808
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Osteoporosis and obesity: Role of Wnt pathway in human and murine models.
    Colaianni G; Brunetti G; Faienza MF; Colucci S; Grano M
    World J Orthop; 2014 Jul; 5(3):242-6. PubMed ID: 25035826
    [TBL] [Abstract][Full Text] [Related]  

  • 70. "Osteotropic" Wnt/LRP Signals: High-Wire Artists in a Balancing Act Regulating Aortic Structure and Function.
    Towler DA
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):392-395. PubMed ID: 28228445
    [No Abstract]   [Full Text] [Related]  

  • 71. Regulation of bone metabolism by Wnt signals.
    Kobayashi Y; Uehara S; Udagawa N; Takahashi N
    J Biochem; 2016 Apr; 159(4):387-92. PubMed ID: 26711238
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways.
    Weivoda MM; Ruan M; Hachfeld CM; Pederson L; Howe A; Davey RA; Zajac JD; Kobayashi Y; Williams BO; Westendorf JJ; Khosla S; Oursler MJ
    J Bone Miner Res; 2016 Jan; 31(1):65-75. PubMed ID: 26189772
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth.
    Duan P; Bonewald LF
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):23-29. PubMed ID: 27210503
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bone remodeling in the context of cellular and systemic regulation: the role of osteocytes and the nervous system.
    Niedźwiedzki T; Filipowska J
    J Mol Endocrinol; 2015 Oct; 55(2):R23-36. PubMed ID: 26307562
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells.
    Florencio-Silva R; Sasso GR; Sasso-Cerri E; Simões MJ; Cerri PS
    Biomed Res Int; 2015; 2015():421746. PubMed ID: 26247020
    [TBL] [Abstract][Full Text] [Related]  

  • 76. TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss.
    Kassem A; Henning P; Kindlund B; Lindholm C; Lerner UH
    FASEB J; 2015 Nov; 29(11):4449-60. PubMed ID: 26207027
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Membrane depolarization regulates intracellular RANKL transport in non-excitable osteoblasts.
    Notomi T; Kuno M; Hiyama A; Ezura Y; Honma M; Ishizuka T; Ohura K; Yawo H; Noda M
    Bone; 2015 Dec; 81():306-314. PubMed ID: 26211991
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Is β-catenin neutralization cross-involved in the mechanisms mediated by natalizumab action?
    Galuppo M; Mazzon E; Giacoppo S; Bereshchenko O; Bruscoli S; Riccardi C; Bramanti P
    Curr Mol Med; 2015; 15(10):990-3. PubMed ID: 26592242
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts.
    Greenblatt MB; Park KH; Oh H; Kim JM; Shin DY; Lee JM; Lee JW; Singh A; Lee KY; Hu D; Xiao C; Charles JF; Penninger JM; Lotinun S; Baron R; Ghosh S; Shim JH
    J Exp Med; 2015 Jul; 212(8):1283-301. PubMed ID: 26195726
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Decursin inhibits osteoclastogenesis by downregulating NFATc1 and blocking fusion of pre-osteoclasts.
    Kim KJ; Yeon JT; Choi SW; Moon SH; Ryu BJ; Yu R; Park SJ; Kim SH; Son YJ
    Bone; 2015 Dec; 81():208-216. PubMed ID: 26208796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.